Lymphokine-Activated Killer (LAK) Cell Activity in Psychiatric Illness
There is now a great deal of evidence that the central nervous system and the immune system are closely interrelated (Ader, 1981). Messengers from the brain are now known to affect immune regulation. Similarly, secretory products of immune cells and tissues can affect brain function. A number of investigators have recently studied the integrity of the immune response in patients with psychiatric disorders. Several immune abnormalities were identified in patients with major depression. These include lymphocytopenia (Kronfol et al., 1984), reduction in circulating T cell numbers (Schleifer et al.,1984), impairment in mitogen-induced lymphocyte proliferation (Kronfol et al., 1983), and a decrease in natural killer (NK) cell activity (Kronfol et al., 1989). Similarly, abnormalities in immune regulation in schizophrenia have also been reported. These include an increase in the number of B lymphocytes, a decrease in NK cell activity, and an increase in the level of specific immunoglobuslins and/or specific antibrain antibodies (DeLisi, 1984).
KeywordsNatural Killer Schizophrenic Patient Psychiatric Illness Psychiatric Patient Immune Regulation
Unable to display preview. Download preview PDF.
- Ader, R., 1981, Psychoneuroimmunology, Academic Press, New York.Google Scholar
- Kronfol, Z., ‘Rimer, R., Nasrallah, H., and Winokur, G., 1984, Leukocyte regulation in depression and schizophrenia, Psychiatry Res. 13: 13–18.Google Scholar
- Nah; M. P. N., and Schwartz, S. A., 1989, Immunegulation of lymphokine-activated killer (LAK) cells, Clin. Immunol. Immunopathol. 49: 28–40.Google Scholar
- Spitzer, R., Endicott, J., and Robins, E., 1977, Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, New York State Psychiatric Institute, New York.Google Scholar